Buy Xaggitin XL Online in UK Without a Prescription.

Xaggitin XL is a prolonged-release formulation of methylphenidate hydrochloride used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 years and over and adults, when non-medication interventions alone have not provided sufficient benefit. Treatment should form part of a comprehensive ADHD management programme under appropriate specialist supervision.

Xaggitin XL is available in 18 mg, 27 mg, 36 mg and 54 mg strengths. Each tablet contains methylphenidate hydrochloride in a prolonged-release formulation designed for once-daily administration when prescribed appropriately.

What Is Xaggitin XL?

Xaggitin XL contains methylphenidate hydrochloride, a centrally acting stimulant medicine. It is prescribed for ADHD and may help improve attention and concentration while reducing impulsive behaviour in appropriate patients.

How Does Xaggitin XL Work?

Methylphenidate affects signalling involving neurotransmitters including dopamine and noradrenaline. Its precise therapeutic mechanism in ADHD is not fully established, but methylphenidate is thought to inhibit their reuptake and increase their availability in the spaces between nerve cells.

Available Strengths

Xaggitin XL is available as:

• Xaggitin XL 18 mg
• Xaggitin XL 27 mg
• Xaggitin XL 36 mg
• Xaggitin XL 54 mg

The appropriate strength is determined individually by the prescribing clinician.

ADHD Treatment

Xaggitin XL is used as part of a broader ADHD treatment programme that can include psychological, educational and social interventions. Medication is not considered a cure for ADHD, and ongoing clinical monitoring is important during treatment.

Safety & Precautions

Xaggitin XL is a prescription-only medicine and should only be used by the person for whom it has been prescribed. Patients should discuss existing heart, circulation or mental-health conditions and any other medicines they take with their doctor or pharmacist before treatment.

Commonly reported adverse effects include nervousness, difficulty sleeping and headache. Patients should consult their healthcare professional if they experience concerning or persistent symptoms.

The prolonged-release tablets are designed to be swallowed whole; the product information specifically states that Xaggitin XL should only be used in patients who can swallow the tablet whole.

Professional Product Information

For the most accurate information about indications, contraindications, interactions, dosing and monitoring, healthcare professionals and patients should consult the current Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL). The current UK electronic Medicines Compendium information was updated in February 2026.